Chandigarh Herald

Innovative Macrophage-Targeted Drug Delivery Solutions at Creative Biolabs

 Breaking News
  • No posts were found

Innovative Macrophage-Targeted Drug Delivery Solutions at Creative Biolabs

November 21
15:05 2022
Equipped with a group of highly educated and experienced scientists and technicians, Creative Biolabs provides an extensive range of accurate and effective solutions for researchers dedicated to developing macrophage therapeutics and continues to expand its solution offering to maintain the leading position in the research market.

New York, USA – November 21, 2022 – Tumor-associated macrophages are essential components of the tumor microenvironment and have a role in cancer cell proliferation, metastasis, and immunosuppression. Thus, macrophage-targeted drug delivery systems have garnered much interest from researchers across the globe. Diverse delivery systems targeting macrophages have been developed and have shown good performance for novel drug inventions based on an in-depth understanding of macrophage-targeted drug delivery systems. Creative Biolabs, backed by state-of-the-art technologies and development platforms, strives to offer ongoing support for solving the scientific and technical obstacles that arise in researchers’ development processes.

“Although using macrophage-targeted drug delivery systems for the treatment of human diseases has revealed great achievements in recent years,” according to a scientist at Creative Biolabs, “further elucidation regarding the macrophage-targeted drug delivery system is required to address existing problems.”

In order to provide researchers with comprehensive solutions for macrophage therapeutic development, Creative Biolabs launches a full set of macrophage-targeted drug delivery system development services based on its cutting-edge platform, including but not limited to macrophage-targeted liposome drug delivery and macrophage-targeted nanoparticle drug delivery systems. The company is committed to serving every client with high-quality and timely feedback, promising to become the most reliable partner in macrophage therapeutic development.

“Recently, an increasing interest in macrophage-targeted nanoparticle drug delivery systems was observed due to the ability of nanoparticles to be preferentially taken up by macrophages, and more importantly, facilitating macrophage-targeted drug delivery without interfering with cell functions,” the scientist continued, “and our specialists have wide experience in this field and have ever created complete and suitable solutions to help customers shorten their project timelines.”

In addition, Creative Biolabs also provides comprehensive solutions for macrophage-targeted liposome drug delivery systems. The professional team at Creative Biolabs has won unanimous praise from customers who are dedicated to the study of macrophage-targeted liposome drug delivery. Moreover, its scientific team is capable of designing solutions tailored to customers’ project needs and offering ongoing support during novel drug development.

To learn more about macrophage-targeted drug delivery services and solutions at Creative Biolabs, please visit

About Creative Biolabs

Creative Biolabs, an industry-leading biotech CRO company specializing in the development of macrophage therapeutics for decades, holds extensive knowledge of macrophage-targeted drug delivery systems and is willing to support researchers working in this field. Scientists from the company will soon represent their innovative drug discovery solutions at the upcoming conferences in December 2022.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States